Skip to main content
European Heart Journal logoLink to European Heart Journal
. 2023 Jul 14;44(36):3423–3439. doi: 10.1093/eurheartj/ehad436

Vegetarian and vegan diets: benefits and drawbacks

Tian Wang 1,2, Andrius Masedunskas 3,4, Walter C Willett 5, Luigi Fontana 6,7,8,9,
PMCID: PMC10516628  PMID: 37450568

Graphical Abstract

Graphical Abstract.

Graphical Abstract

A comparison of healthy vegetarian diets vs. unhealthy vegetarian diets. HbA1c, glycosylated haemoglobin; LDL-C, low-density lipoprotein cholesterol.

Keywords: Nutrition, Plant-based diets, Vegetarian, Vegan, Cardiovascular disease, Diabetes, Hypertension, Obesity, Dementia, Cancer

Abstract

Plant-based diets have become increasingly popular thanks to their purported health benefits and more recently for their positive environmental impact. Prospective studies suggest that consuming vegetarian diets is associated with a reduced risk of developing cardiovascular disease (CVD), diabetes, hypertension, dementia, and cancer. Data from randomized clinical trials have confirmed a protective effect of vegetarian diets for the prevention of diabetes and reductions in weight, blood pressure, glycosylated haemoglobin and low-density lipoprotein cholesterol, but to date, no data are available for cardiovascular event rates and cognitive impairment, and there are very limited data for cancer. Moreover, not all plant-based foods are equally healthy. Unhealthy vegetarian diets poor in specific nutrients (vitamin B12, iron, zinc, and calcium) and/or rich in highly processed and refined foods increase morbidity and mortality. Further mechanistic studies are desirable to understand whether the advantages of healthy, minimally processed vegetarian diets represent an all-or-nothing phenomenon and whether consuming primarily plant-based diets containing small quantities of animal products (e.g. pesco-vegetarian or Mediterranean diets) has beneficial, detrimental, or neutral effects on cardiometabolic health outcomes. Further, mechanistic studies are warranted to enhance our understanding about healthy plant-based food patterns and the biological mechanisms linking dietary factors, CVD, and other metabolic diseases.

Introduction

Plant-based diets have become increasingly popular thanks to their purported health benefits and more recently for their positive environmental impact.1 There are different types of plant-based diets, but in this review, we will focus our attention primarily on vegan (100% plant-based), lacto-ovo vegetarian (i.e. plant-based except for dairy products and/or eggs), and pesco-vegetarian or pescatarian (i.e. plant-based except for fish and seafood with or without eggs and dairy) diets. All vegetarian diets exclude meat (e.g. beef, pork, lamb, venison, chicken, and other fowl) and related meat products.

According to the American and Canadian Dietetic Associations, appropriately planned and supplemented vegan and lacto-ovo vegetarian diets are nutritionally adequate and suitable for individuals in all stages of the life cycle and may provide health benefits in disease prevention and treatment.2,3 These statements are supported mainly by cross-sectional and prospective studies with accumulating data from a limited number of clinical randomized trials. Moreover, not all plant-based foods are equally healthy. Vegetarian diets rich in refined flours, hydrogenated oils, high-fructose corn syrup (HFCS), sucrose, artificial sweeteners, salt, and preservatives have been shown to increase morbidity and mortality (Figure 1).4–6 The purpose of this article is to review succinctly the current knowledge on the effects of vegetarian diets on the risk of developing some of the most common and costly chronic diseases, including cardiovascular disease (CVD), obesity, type 2 diabetes mellitus (T2DM), hypertension, dementia, and cancer, and to discuss what is known about its metabolic and molecular adaptations and effects.

Figure 1.

Figure 1

Metabolic effects of healthy and unhealthy vegetarian diets. MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides.

Evidence acquisition

We searched EMBASE, MEDLINE, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), and PubMed, from inception until 20 September 2022. Hand searches of reference lists of reviews, protocols, and clinical trial registries (ClinicalTrials.gov) were performed to supplement searches. Search terms included diet, plant-based, vegetarian, vegan, cardiovascular, cardiovascular diseases, diabetes, T2DM, hypertension, cancer, dementia, and cognitive function. The authors of the ongoing trials were contacted to retrieve preliminary findings and full manuscripts. Both basic science and clinical research studies were reviewed. The published clinical reports that we reviewed included epidemiologic studies, case-control studies, and randomized controlled trials. Quality of data was assessed by taking into account publication in a peer-reviewed journal, number of individuals studied, objectivity of measurements, and techniques used to minimize bias.

Metabolic and molecular mechanisms associated with vegetarian diets

The precise mechanisms by which well-designed and balanced vegetarian or vegan diets may exert their beneficial effects in lowering the risk of coronary heart disease (CHD) and possibly cancer and dementia are under scrutiny. Many factors have been hypothesized to play a role, including (i) lipid-lowering effect; (ii) glucose-lowering, insulin sensitizing, and hormonal effects; (iii) protection against oxidative stress, inflammation, and hypertension, and (iv) production of intestinal microbial metabolites influencing metabolic and immune health (Figure 2).

Figure 2.

Figure 2

Cardioprotective mechanisms of healthy vegetarian diets. Multiple nutritional effectors of a healthy vegetarian diet modulate important metabolic, hormonal, and immune factors associated with the development of cardio- and cerebrovascular diseases. K, potassium; Mg, magnesium; Se, selenium; NaCl, sodium chloride; SCFA, short-chain fatty acids; LDL-C, low-density lipoprotein cholesterol; VLDL, very-low-density lipoprotein; GI, glycaemic index; BCAA, branched-chain amino acid; TMAO, trimethylamine N-oxide.

Lipid-lowering effect

Several factors can explain why vegetarians have significantly lower levels of plasma cholesterol, especially when they consume minimally processed plant foods. Vegetarians do not consume meat, and vegans also avoid milk, butter, and dairy. Beef, lamb, and pork contain high levels of saturated fat and cholesterol and minimal amounts of polyunsaturated fats; even lean cuts of beef may contain up to 4.5 g of saturated fat per 100 g serving. One-cup serving of whole milk contains 4.5 g of saturated fat, and one tablespoon of butter contains 102 kcal and 7 g of saturated fat. In contrast, one tablespoon of olive oil contains 119 kcal and only 1.9 g of saturated fatty acids. Epidemiological studies have shown a strong linear relationship between saturated fat intake, plasma cholesterol levels, and CHD.7,8 Substituting 5% of energy intake from saturated fatty acids with a similar quantity of energy from polyunsaturated fats, monounsaturated fats, or carbohydrates from whole grains is associated with a 25%, 15%, and 9% lower risk of CHD, respectively. However, when saturated fats are replaced with carbohydrates from refined carbohydrates, the risk of developing CHD increases substantially.9 Data from randomized clinical trials have demonstrated a cause–effect relationship;10–12 replacing saturated fat with vegetable polyunsaturated fats decreases CHD by 30% that is similar to the reduction induced by statin therapy.13 Seeds and nuts are excellent sources of polyunsaturated fatty acids and contain soluble and insoluble fibres and sterols that are known to lower cholesterol.14 Epidemiological studies suggest that frequent nut consumption can reduce the risk of CHD by 40%–60%.15 Data from randomized clinical trials confirm that consuming a diet rich in nuts, viscous fibres from oats, barley, psyllium, and plant sterol ester–enriched margarine can reduce plasma low-density lipoprotein (LDL) cholesterol by 13%.16 Moreover, vegetarian diets rich in whole grains, legumes, nuts, and dried fruits can provide ∼15 g of dietary fibre per 1000 kcal. In a 4 month weight loss double-blind, placebo-controlled clinical trial, overweight or obese men and women who received a daily supplement of soluble fibre (3 g Plantago ovata husk and 1 g glucomannan) experienced a significant greater drop in LDL cholesterol than those in the placebo group.17 Dietary fibres and phytosterols reduce the (re)absorption of cholesterol and bile acids in the small intestine, thus resulting in an increased LDL uptake by the liver.18,19 Moreover, foods rich in dietary fibre and with low glycaemic index can lower insulin production and increase the levels of short-chain fatty acids produced by fibre fermentation, which have both been shown to inhibit cholesterol synthesis.19

Glucose-lowering, insulin sensitizing, and hormonal effects

Vegetarians, and especially vegans, tend to have lower body weights than omnivores. In a survey of the American Adventists population, average body mass index (BMI) in omnivores, semi-vegetarians, lacto-ovo vegetarians, and vegans was 28.3, 27.3, 26.1, and 24.1 kg/m2, respectively.20 Although consuming a vegetarian diet does not require counting calories, results from clinical trials demonstrate that people randomized to a vegetarian diet tend to lose more weight than those consuming Western diets.21,22 Preclinical, epidemiological, and clinical studies suggest that distinct dietary interventions may promote atherogenic and metabolic fat depot mobilization differently.23 The high-fibre and water content and lower energy density of vegetables, legumes, and whole grains may in part explain this effect. Consumption of diets rich in dietary fibre induces gastric distention, delays gastric emptying, and prevents large fluctuations in postprandial blood glucose.24 Short-chain fatty acids produced by the intestinal microbial metabolism of resistant starch and oligosaccharides of minimally refined plant foods induce satiety by inhibiting gastric emptying through incretins such as peptide-YY and glucagon like peptide-1 that markedly reduce blood glucose and body weight in randomized clinical trials.25–27 Moreover, whole-food vegan and vegetarian diets may result in fewer bioavailable calories, and it is well known that calorie restriction with adequate nutrition in humans exert a powerful effect in improving glucose tolerance, insulin sensitivity, and many other cardiometabolic, inflammatory, and hormonal factors implicated in the pathogenesis of CVD and cancer.28–30 As reviewed elsewhere,28,31 excessive (central) adiposity causes insulin resistance, dysregulation of sex hormones and insulin-like growth factor-1 (IGF-1) signalling, low-grade chronic inflammation, and immune dysregulation of natural killer cells and stromal tumour-infiltrating lymphocytes, limiting antitumour responses. Compensatory hyperinsulinaemia together with increased bioavailability of oestradiol, testosterone, and IGF-1 promotes cell proliferation and genomic instability through activation of the PI3K/AKT and p66shc pathways, which have been associated with increased risk of multiple cancers, including breast, endometrial, prostate, and colon cancer.28,31

Additional mechanisms mediating the insulin sensitizing and glucose-lowering effects of healthful minimally processed vegetarian diets are the low glycaemic index/load and the lower intake of protein, especially of sulphur and branched-chain amino acids. Estimated daily protein intake for omnivores in Western societies is ∼90–100 g of which ∼70%–85% is animal proteins rich in methionine, valine, leucine, and isoleucine. Results from both population and randomized experimental diet interventions show that high protein intake, especially of branched-chain amino acids, is associated with an increased prevalence and risk of developing pre-diabetes and T2DM.32 Diabetes risk increases by 20%–40% for every 10 g of protein consumed in excess of 64 g per day.33,34 Interestingly, in some studies, high intake of animal protein, but not of plant protein, was associated with the higher risk of developing T2DM.32,34,35 In weight loss trials of obese women, high protein intake (1.3 g kg−1 per day including two servings of a whey protein isolate) completely prevented the markedly improved insulin sensitivity observed in women consuming a normal protein diet (0.8 g kg−1 per day) who lost the same amount of body weight and visceral and liver fat.36 Furthermore, dietary branched-chain amino acid (BCAA) restriction in mice recapitulates many of the beneficial effects of protein restriction observed in rodents and humans, including reduced adiposity, increased glucose tolerance, and increased energy expenditure, but not increased FGF21 levels.37 In contrast, high dietary intake of BCAA increases platelet activation and arterial thrombosis risk by enhancing tropomodulin-3 propionylation.38 Consistently, data from two trials demonstrated that consuming high-protein diets (comprising dairy and meat products and whey protein supplements) cause a reduction in insulin sensitivity and an associated increase in blood insulin levels.39,40 In an another trial of patients with T2DM, high consumption of chicken, fish, eggs, low-fat milk, and cheeses prevented the expected improvements in glucose metabolism and insulin sensitivity induced by a 2 month weight loss intervention.41 High-protein diets, particularly those rich in leucine, can also play a role in promoting atherosclerosis and plaque instability in mice by exacerbating macrophage apoptosis induced by atherogenic lipids, via mTORC1-dependent inhibition of mitophagy and accumulation of dysfunctional mitochondria.42

Protection against oxidative stress, inflammation, and hypertension

Well-designed vegetarian diets rich in vegetables, whole grains, legumes, nuts, seeds, and fruits provide a wide range of vitamins (vitamin C, vitamin E, and beta-carotene), minerals (selenium), and phytochemicals (tannins, phenols, alkaloids, and flavonoids) with xenohormetic effects.43 Numerous large observational studies suggest that an inverse relationship exists between antioxidant and polyphenol intake and the risk of developing diabetes, CVDs, cancer, and possibly dementia.44 High intake of dietary antioxidants and phytochemicals may reduce the risk of developing atherosclerotic plaques because it triggers adaptive modulations of stress-response enzymes and receptors that prevent lipoprotein oxidation, endothelial dysfunction, and immune activation.45,46 Findings from large prospective studies suggest that dietary patterns with higher inflammatory potential are significantly associated with higher level of systemic and vascular inflammation, an unfavourable lipid profile, and ultimately with a higher incidence of CHD and stroke.47 Dietary patterns with lower inflammatory potential are those that favour foods rich in dietary antioxidants and vegetable fibre (e.g. green leafy and dark yellow vegetables, whole grains, fruit, tea, and coffee) and avoid red and processed meat and refined liquid and solid carbohydrates.48–52

Diets rich in vegetable fibre, potassium, and magnesium and low in sodium, especially when associated with a healthy body weight and regular endurance exercise training, markedly lower systolic and diastolic blood pressure,53–56 which is a powerful risk factor for the development of CHD, heart failure, stroke (both ischaemic and haemorrhagic), and dementia. Indeed, data from epidemiological and genetic causal inference studies show that elevated systolic blood pressure, insulin resistance, and excess adiposity at midlife are important risk factors for developing cognitive impairment and Alzheimer’s disease because they cause endothelial dysfunction and vascular damage to the brain, particularly at the level of perforating cerebral arteries and neurovascular units.57,58 In contrast, reduction of systolic blood pressure prevents and/or slows progression of cognitive impairment to dementia.59

Modulation of gut microbiome function and effect on human metabolic state

Diet composition has a pervasive effect in modulating systemic microbiome biology. Metagenomic data show that specific nutrients, especially insoluble fibre, and protein intake deeply influence gut microbiota structure and function and the production of a growing list of metabolically active molecules.60,61 For instance, unlike vegetarians diets, Western diets rich in red meat, eggs, and cheese contain higher concentrations of nutrients such as choline and L-carnitine that increase the microbial production of trimethylamine N-oxide (TMAO).62,63 Animal and human studies have shown that higher levels of circulating TMAO increase the risk of developing CVD, independent of traditional cardiometabolic risk factors, by inducing vascular inflammation and platelet activation.64,65 In contrast, healthful plant-based diets rich in whole grains, legumes, and nuts can markedly increase the intake of dietary fibres, key fermentable substrates for the proliferation of Bacteroidetes and the production of short-chain fatty acids such as acetate, propionate, and butyrate.66,67 Experimental animal data indicate that these microbial metabolites exert powerful blood pressure–lowering and immune-modulating effects, via activation of specific G-protein–coupled receptors expressed on enteroendocrine and intestinal immune cells.61,68 Long-term consumption of vegetarian diets has also been associated with more phylogenetic biodiversity of stool microbiota; in contrast, multigenerational exposure to Western diets poor in ‘microbiota-accessible carbohydrates’ causes an extinction of specific bacterial lineages, which impairs immune function and maturation, and increases the risk of developing a range of metabolic, inflammatory, allergic, and autoimmune diseases.69,70 Interestingly, data from the DIRECT-PLUS trial show that a calorie-restricted and (almost) red-meat-free version of the Mediterranean diet enriched in plant-based proteins (Green-MED diet) is superior to the classical Mediterranean diet in improving the 10-year Framingham risk score and in lowering waist circumference, intrahepatic fat, LDL cholesterol, diastolic blood pressure, C-reactive protein, and HOMA insulin resistance.71 These cardiometabolic beneficial effects were partially mediated by a major shift in the composition and function of the gut microbiome, including enrichments in the genus Prevotella and reductions in the genus Bifidobacterium with associated inhibition in BCAA biosynthesis and up-regulation of BCAA degradation enzymatic pathways.72 This is crucial because a growing body of evidence show that reprogramming microbial functions through long-term adherence to healthier plant-rich diets has profound effects in shaping physiologic response to specific nutrients, to calorie restriction, and to other features of host biology that are instrumental in promoting health and longevity.73,74

Evidence from prospective studies

Prospective epidemiological studies have suggested that consuming vegetarian diets might have protective effects against the development of obesity, diabetes, hypertension, CHD, several type of cancers, and, most recently, cognitive decline. Whether these associations are causal deserves careful consideration of all available evidence, including data from other types of studies.

Hypertension

Findings from observational studies suggest that people consuming vegetarian and vegan diets have lower blood pressure than people eating Western diets, even after adjusting for age, sex, and BMI.75 Compared with Seventh-day Adventist who are omnivores, those who follow a vegetarian diet have lower blood pressure and a reduced incidence of hypertension, independent of body weight and sodium intake.76 Data from multiple observational studies including three large prospective American cohort studies suggest that consuming red meat and poultry is associated with an increased risk of hypertension, independent of vegetable, whole grain, and fruit intake.77

Type 2 diabetes mellitus

Several studies suggest protective effects of vegetarian diets in the prevention of T2DM. Findings from the Adventist Health Study-2 (41 387 participants free of diabetes followed for 2 years) found that, even after controlling for multiple confounding factors, vegetarians had a significantly lower risk of T2DM than omnivores.78 The most apparent protective effect was for vegan diets with a 62% risk reduction, followed by semi-vegetarian (51% reduction) and lacto-ovo vegetarian (38% reduction) diets. The Adventist Mortality Study and Adventist Health Study followed a cohort of 8401 individuals for more than 17 years.79 After controlling for weight and weight change, long-term adherence to a diet incorporating weekly meat intake was associated with a 38% higher risk of T2DM compared with a vegetarian diet with no meat intake. This finding are supported by data from a joint analysis of three large cohort studies (the Health Professionals Follow-up Study, n = 26,357; the Nurses’ Health Study, n = 48,709; and the Nurses’ Health Study II, n = 74,077) confirming a statistically significant association between red meat consumption and an increased risk of T2DM (P < .001 for all studies).80 After adjusting for initial BMI and concurrent weight gain, a daily increase of > 0.5 servings of red meat was linked with a 30% higher risk of T2DM. In contrast, reducing red meat intake by > 0.5 servings/day was associated with a 14% lower risk of T2DM.

Cardiovascular disease

A joint analysis of five prospective studies including 76 172 individuals has shown a lower CHD mortality in vegetarians than in omnivores: 34% less in lacto-ovo vegetarians and pesco-vegetarians and 26% lower in vegans.81 Another meta-analysis of 7 studies (124 706 participants) report a 29% decreased mortality from CHD in vegetarians than omnivores.82 The EPIC-Oxford cohort study (44 561 participants) showed a 32% risk reduction of CHD in vegetarians than non-vegetarians.83 However, subsequent studies suggest that the protective effect against CHD of vegetarian diets seems to be almost exclusively limited to the Seventh-day Adventists, who don’t smoke, don’t drink alcohol, do regular physical activity, and are very religious and socially connected.84 Indeed, data from epidemiological studies of English and German vegetarians show only a modest protective effect against cardiovascular and overall mortality.85–87 A German prospective study of 1225 vegetarians and 679 health-conscious non-vegetarians has shown that there is no difference in mortality among vegetarians and this control group of health-conscious individuals consuming meat three to four times per month.88 Cigarette smoking, obesity, alcohol intake, and exercise patterns seem to explain most of the differences in cardiovascular mortality among these different groups. Another potential problem is diet quality, which can vary greatly among both vegetarian and non-vegetarians.4,5,89

The effects of vegetarian diets on major cardiometabolic risk factors (i.e. hypercholesterolaemia, dyslipidaemia, hypertension, T2DM, and obesity) are more consistent. Well-educated vegetarians who consume balanced diets tend to have a lower body weight than non-vegetarians21 together with lower levels of cholesterol, glucose, and blood pressure.90 A recent umbrella review integrated evidence from 20 meta-analyses and found that people following vegetarian diets had significantly lower total cholesterol and LDL cholesterol than people consuming Western diets.91 On average, total and HDL cholesterol are ∼0.36 and 0.10 mmol/L, respectively, lower in vegetarians than in omnivores.92

Cancer

A meta-analysis of 7 epidemiological studies (124 706 participants) found an 18% lower cancer incidence in vegetarians than omnivores {relative risk [RR]: 0.82 [95% confidence interval (CI): 0.67, 0.97]}.82 Results from the EPIC-Oxford study on a cohort of 65 000 men and women found that the overall cancer risk was 10% lower in vegetarians and 18% lower in vegans than in meat-eaters.93 However, after correcting for multiple confounding factors, only stomach and haematological cancers were significantly lower, while cervical cancer was 90% higher in vegetarians. Recent data from the UK Biobank prospective study on 409 110 participants show that compared with omnivores, vegetarians had a 13% and pescatarians a 7% lower overall cancer risk, respectively. In this study, vegetarians had a lower risk of colorectal and prostate cancer, and pescatarians had a lower risk of melanoma. However, when these data were pooled with eight previously published studies in a meta-analysis, only the association with colorectal cancer persisted.94 These findings suggest that other factors beyond vegetarian diets may explain these associations. The incidence of lung cancer, for example, is lower in vegetarians than in people consuming typical Western diets, but this seems due primarily to the reduced smoking habit of vegetarians. No difference has been reported for lung cancer risk for vegetarians in maximally adjusted models.95–97 The incidence of colon cancer is reduced by 22% among Seventh-day Adventist vegetarians, but not in British vegetarians. In the latter group, for example, it seems that vegans have an even higher risk of colon cancer, while in pesco-vegetarians, there is a 33% reduction, even after correcting for body weight.95 The quality of diet probably plays a major role. Indeed, unhealthy plant-based diets rich in refined and processed carbohydrates and unhealthy fats are associated with higher risk of colon cancer, but healthy plant-based diets enriched in whole grains, legumes, and vegetables are associated with lower incidence of colorectal cancer, especially KRAS-wildtype subtype.6 The risk of developing breast cancer is no different between vegetarian and non-vegetarian women in most studies, and some epidemiological data in Adventist and British women suggest vegans, but not lacto-ovo vegetarians, may have an increased risk.98 The same is true for prostate cancer, with the risk no different among lacto-ovo vegetarians and omnivores but 34% lower in the Adventists vegans.99 A lower intake of dairy products may explain this association because milk consumption increases serum IGF-1 levels, a risk factor for prostate cancer, breast, and colon cancer.100

Dementia

Very little is known about the effects of vegetarian diets on cognitive function and dementia risk. A recent systematic review and meta-analysis suggests that vegetarian diets are not associated with any significant improvement in memory when compared with omnivorous diets, but heterogeneity among studies was very high.101 Findings from a small prospective study (5710 participants with 121 incident cases) conducted in Taiwan suggest that vegetarians might have a lower risk of dementia than non-vegetarians.102

Evidence from randomized clinical trials

Hypertension

Data from a meta-analysis of 7 clinical trials including 311 participants show that consuming a vegetarian diet is associated with a reduction of mean systolic [−4.8 mmHg (−6.6 to −3.1)] and diastolic [−2.2 mmHg (−3.5 to −1.0)] blood pressure compared with non-vegetarian diets.103 A meta-analysis of 11 trials and 983 participants showed that strict plant-based (vegan) diets seem less effective than less restrictive diets and reduced systolic [−4.10 mmHg (−8.14 to −0.06)] and diastolic [−4.01 mmHg (−5.97 to −2.05)] blood pressure only in patients with a baseline systolic blood pressure (SBP) ≥130 mmHg.104 A recent meta-analysis of randomized trials show that the lacto-ovo vegetarian diet is as effective as other healthy diets containing some animal products [Dietary Approaches to Stop Hypertension (DASH) and healthy Nordic diet] at reducing blood pressure. In contrast, vegan diets did not significantly reduce blood pressure unless caloric restrictions was also prescribed,105 suggesting that complete elimination of animal food is not required for lowering blood pressure and might even increase haemorrhagic stroke risk, possibly due to very low intake of saturated fat.93 Other factors such as calorie restriction and weight loss,30,54,106 lower dietary sodium and high potassium and magnesium intake,53,55 and regular endurance exercise training56 are important factors beyond fibre-rich plant food consumption. Moreover, findings from a meta-analysis of 15 randomized trials show that reduced alcohol consumption dose-dependently lowers systolic and blood pressure in both in non-hypertensive and hypertensive individuals.107

Type 2 diabetes mellitus

The results of a recent meta-analysis of nine randomized clinical trials provide evidence that vegetarian diets can significantly reduce fasting glucose (range 0.1–1.0 mmol/L) and glycosylated haemoglobin (HbA1c) (range 0.12%–0.45%) together with LDL cholesterol (range 0.04–0.2 mmol/L) and body weight (range 1.3–3.0 kg) in T2DM patients.108 Interestingly, one randomized clinical trial comparing a low-fat vegan diet with the American Diabetes Association (ADA) diet demonstrated that both diets caused significant improvements in HbA1c, body weight, plasma lipid concentrations, and urinary albumin excretion in individuals with T2DM.109 Forty-three percent of patients randomized to the vegan group and 26% of those allocated to the ADA group reduced the use of glucose-lowering drugs. Moreover, among medication-stable patients, the effects of the low-fat vegan diet on HbA1c, weight, waist circumference, and LDL cholesterol were significantly greater than in the control group. Similar improvements in HbA1c levels have been found in a population of Korean men and women affected by T2DM.110 Thus, these trials suggest that low-fat vegan diets might be more effective than conventional diabetic diets in glycaemic control, but more studies with long-term follow-up are needed to confirm these findings. Table 1 summarizes the ongoing clinical trials with vegetarian diet interventions in people with T2DM.

Table 1.

Study characteristics of completed and ongoing clinical trials in people with type 2 diabetes mellitus

Author, year, country Study design; intervention duration Registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description Relevant biomarkers [MD (95% CI)]
Intervention Comparison
Barnard et al., 2006,109 USA 22 weeks, randomized, controlled trial, parallel arm; 52 weeks follow-up NCT00276939; completed trial (1) The LF vegan Diet (49)
(2) The ADA diet (50)
T2DM and being overweight (BMI ≥ 25 kg/m2); gender: (1) 27 F, 22 M; (2) 33 F, 17 M; mean age (range): (1) 57 (35–82); (2) 55 (27–80) The LF, vegan diet: no animal products and added fats; consisted of F & V, grains, and legumes, favour low-GI foods; vitamin B12 supplement (100 mcg) taken every other day The ADA diet: participants (with BMI >25 kg/m2) were prescribed 500–1000 kcal energy deficits; vitamin B12 supplement (100 mcg) to be taken every other day LDL: −0.02 [−0.31, 0.27] mmol/L; HbA1c: −0.40 [−0.85, 0.05]%; SBP: −0.2 [−5.4; 5.0] mmHg
Barnard et al., 2018,111 USA 20 weeks, randomized, controlled trial, parallel arm NCT01222429; completed trial (1) The LF vegan diet (22)
(2) The portion-controlled eating plan (23)
T2DM (HbA1c 6.5%–10.5%) and overweight (BMI ≥ 25 kg/m2); gender: (1) 13 F, 9 M; (2) 11 F, 12 M; mean (range): (1) 62 (41–79); (2) 61 (30–75) The LF, low-GI, vegan diet: consisted of whole grains, F & V, and legumes; no animal products and added oils; no restrictions on energy or carbohydrate intake The portion-controlled eating plan: energy limits when needed for weight loss (calorie-restricted −500 kcal/d) and guidance on portion sizes LDL: 0.06 [−0.01, 0.13] mmol/L; SBP: 5.5 [2.7, 8.3] mmHg
Author, year, country Study design; Intervention duration Registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description Relevant biomarkers (MD[95%CI])
Intervention Comparison
Bunner et al., 2015,112 USA 20 weeks randomized, parallel arm, controlled trial NCT01690962; completed trial (1) The LF vegan diet + B12 supplement (17)
(2) No intervention + B12 supplement (17)
T2DM with painful diabetic neuropathy for ≥6 months; gender: (1) 11 F, 6 M; (2) 8 F, 9 M; mean age: (1) 57 ± 6; (2) 58 ± 6 The LF, vegan diet first: no animal products; focused on grains, F & V, and legumes; limited fat to 20–30 g/d; favoured low-GI foods; daily vitamin B12 (1000 mcg) No dietary change except for daily vitamin B12 supplement (1000 mcg) LDL: −0.21 [−0.65, 0.23] mmol/L; HbA1c: −0.80 [−1.51, −0.09] %; SBP: −7.2 [−20.1, 5.7] mmHg
Kahleova et al., 2011,113 Czech Republic 24 weeks RCT, open, parallel arm. The second 12 weeks were combined with aerobic exercise. NCT00883038; completed trial (1) The lacto-vegetarian diet (37)
(2) Conventional diabetic diet (37)
T2DM (HbA1c 6%–11%) and being overweight (BMI 25–53 kg/m2); gender: (1) 20 F, 17 M; (2) 19 F, 18 M; mean age (years): (1) 55 ± 7.8; (2) 58 ± 4.9 The lacto-vegetarian diet: consisted of grains, F & V, and legumes; animal products limited to ≤1 portion of LF yogurt/d; vegetarian meals provided in vegetarian restaurants; calorie-restricted (−500 kcal/d); daily vitamin B12 supplement (50 mcg) The conventional diabetic diet: follow dietary guidelines of the DNSG or the EASD; meals provided; calorie-restricted (−500 kcal/d); daily vitamin B12 supplement (50 mcg) LDL: −0.04 [−0.28, 0.20] mmol/L; HbA1c; −0.09 [−0.49, 0.31]%
Author, year, country Study design; Intervention duration Registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description Relevant biomarkers (MD[95%CI])
Intervention Comparison
Lee et al., 2016,114 Korea 12 weeks, randomized, controlled trial, parallel arm CRiS KCT0001771; completed trial (1) The vegan diet + brown rice (53)
(2) The conventional diabetic diet (53)
T2DM (HbA1c 6.0%–11.0%); gender: (1) 40 F, 6 M; (2) 35 F, 12 M; mean age: (1) 57.5 ± 7.7 (2) 58.3 ± 7.0 The vegan diet + brown rice: consisted of F & V, whole grains, and legumes; no animal products, white rice, and processed food made of rice/wheat flour; have brown rice; favour low-GI foods; energy intake, and portion sizes not restricted The conventional diabetic diet: followed the treatment guidelines by the Korean Diabetes Association (2011); restrict individualized daily energy intake based on weight, physical activity, need for weight control, and compliance LDL: −0.04 [−0.29, 0.21] mmol/L; HbA1c: −0.30 [−0.61, 0.01] %; SBP: 2.5 [−4.4, 9.4] mmHg
Nicholson et al., 1999,115 USA 12 weeks randomized controlled trial, parallel arm Completed trial (1) The LF vegan diet (7)
(2) The conventional LF diet (6)
T2DM; gender: (1) 3 F, 4 M; (2) 2 F, 2 M; mean (range): (1) 51 (34–62); (2) 60 (51–74) The LF vegan diet: no animal products, added oils, and refined carbohydrates; consisted of F & V, whole grains, and legumes; the diet was adequate in all nutrients except vitamin B12 The LF diet: emphasized fish and poultry, rather than red meat HbA1c: −0.40 [−2.00, 1.20] %; SBP: 8.5 [−9.1, 26.1] mmHg
Author, year, country Study design; Intervention duration Study name/registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description
Intervention Comparison
Campbell et al. 2018,116 USA RCT, crossover design, each for 2 weeks with a 4–6 week washout NCT 05414851; not yet recruiting (1) WFPB diet (20)
(2) Low-carbohydrate diet (20)
Aged >50y with diagnosis of: hypertension or hyperlipidaemia or pre-diabetes or diabetes or obesity The WFPB diet: exclude animal foods, oils, and solid fats The low-carbohydrate diet: ‘nut’ carbs <50 g/d
Kahleova et al., 2019,117 USA 22 weeks, RCT, crossover design NCT04088981; not yet recruiting (1) The LF vegan diet (30)
(2) The portion-controlled diet (30)
Individuals aged ≥ 18 years with T2DM and BMI 26–40 kg/m2 The LF, vegan diet: no animal products and added oils; no restriction on energy intake The portion-controlled diet: an individualized diet; reduce 500 kcal/d for overweight participants
Sangeetha et al., 2018, India Randomized, parallel arm trial CTRI/2018/10/015896; NI on recruitment (1) Vegetarian diet
(2) Mixed diet
T2DM Vegetarian diet: consume the prescribed vegan, pesco-, and ovo-lacto-vegetarian diet Diabetics on mixed diet: the prescribed non-vegetarian diet
Wright et al., 2017,118 New Zealand 10 weeks RCT, parallel arm; 42 weeks follow-up ACTRN12617000541303; results not published yet (1) WFPB diet (24)
(2) Usual care (24)
Obese (BMI ≥ 30 kg/m2) and T2DM/pre-diabetes WFPB approach: avoid animal products; no energy restriction; daily 50 mcg vitamin B12 supplement Usual care

ADA, American Diabetes Association; CI, confidence interval; F & V, fruits and vegetables; HbA1c, haemoglobin A1c; LDL-C, low-density lipoprotein cholesterol; LF, low-fat; LOV, lacto-ovo vegetarian diet; MD, mean differences; SBP, systolic blood pressure; DNSG, Diabetes and Nutrition Study Group; EASD, European Association for the Study of Diabetes; NA, not applicable; RR, relative risk; F, females; M, males; NI, no information; OR, odds ratio; RCT, randomized controlled trial; IQR, interquartile range; M, males; WFPB, whole foods plant-based.

Cardiovascular disease

Randomized clinical trials are usually considered gold standard studies for evaluating the cause–effect relationship of health interventions, although misleading conclusions can easily occur due to low adherence to the intervention or inadequate follow-up time. To the best of our knowledge, there are no randomized clinical trials that have tested the effects of vegetarian diets alone on CHD event rates. The Lifestyle Heart Trial was designed to investigate the effects of an intensive lifestyle programme comprising a 10% fat whole foods vegetarian diet together with aerobic exercise, stress management training, smoking cessation, and group psychosocial support in 48 patients with moderate to severe CHD.119 Only 20 of the 28 patients randomized to the experimental group completed the 5-year follow-up and experienced a small but significant regression of coronary atherosclerosis (a 7.9% relative improvement) and a decrease in symptomatic and scintigraphic myocardial ischaemia.119,120 In contrast, patients randomized to the usual care control group who completed the study (n = 15) experienced a 27.7% relative worsening of the average percent diameter stenosis. However, this was a very small, under-powered study that does not allow to differentiate the effects of the vegetarian regimen from those induced by the very low-fat diet, regular aerobic exercise, smoking cessation, and stress reduction programme.

Many randomized clinical trials have tested the effects of different forms of vegetarian diets on cardiometabolic risk factors. Recent meta-analyses reported that vegetarian diets significantly improve several risk factors, including body weight (1.2–2.8 kg reduction),121 SBP (3.3–7.6 mmHg reduction),103,105 total cholesterol (0.32–0.76 mmol/L reduction), LDL cholesterol (0.32–0.59 mmol/L reduction), high-density lipoprotein (HDL) cholesterol (0.088–0.093 mmol/L reduction),122 and HbA1c (0.15%–0.65% reduction).123 A crossover randomized trial showed that a vegetarian diet was as effective as the Mediterranean diet in reducing body weight and fat mass, but the former resulted in significantly lower LDL cholesterol levels in middle-aged men and women.22 However, many of these meta-analyses were focused on relatively healthy populations or did not stratify patients for gender and disease status. Evidence of the metabolic effects of plant-based diets in people with CVD is limited. Table 2 summarizes the ongoing clinical trials with vegetarian diet interventions in people with CVD.

Table 2.

Study characteristics of completed and ongoing clinical trials in people with cardiovascular diseases

Author, year, country Study design; intervention duration Study name/registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description Relevant biomarkers [MD (95%CI)]
The vegetarian diet Comparison
Aldana et al., 2007,124 USA 1 year RCT, parallel arm Completed trial (1) The Dr. Ornish Programme (46)
(2) Traditional cardiac rehabilitation (47)
CHD; males: (1) 47.8%; (2) 64.6%; mean age: (1) 60.9 ± 9.7; (2) 62.2 ± 8.9 The very LF, LOV diet: no animal proteins except for non-fat dairy and egg whites; liberal consumption of F & V, whole grains, and legumes; one serve of soy food/day; a multivitamin and a flax source of omega-3-fatty acids No dietary intervention: traditional cardiac rehabilitation LDL-C: −0.07 (−0.39, 0.25) mmol/L; SBP: 0.6 (−6.8, 7.9) mmHg
Ornish et al., 1990,119,125 USA Initially 1 year RCT, but extended the study for an additional 4 years, parallel arm Completed trial (1) The LF LOV diet (53)
(2) Usual care (40)
CHD; gender: (1) 1 F, 21 M; (2) 4 F, 15 M; mean age: (1) 56.1 ± 7.5; (2) 59.8 ± 9.1 The LF (10% energy from fat), LOV diet: consisted of F & V, grains, legumes, and soybean products; no animal proteins except for non-fat dairy and egg whites; vitamin B12 supplemented; no calorie restriction; salt restricted for hypertensive patients; caffeine eliminated, alcohol limited to ≤2 units/d Usual care: not asked to make lifestyle changes SBP: 2.0 (−10.2, 14.2) mmHg
Author, year, country Study design; Intervention duration Study name/registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description Relevant biomarkers (MD[95%CI])
The vegetarian diet Comparison
Shah et al., 2018,126,127 USA 8 weeks RCT, open-label, blinded, parallel arm NCT02135939; completed trial (1) The vegan diet (50)
(2) The AHA diet (50)
CHD: > 3/4 had dyslipidaemia. gender: (1) 57 F, 43 M; (2) 58 F, 42 M; median age (IQR): (1) 63.0 (57.0–68.0); (2) 59.5 (53.0–67.0) The vegan diet: whole-food plant-based diet with no processed foods; no animal products; vitamin B12–fortified soy milk; given the cookbooks Simply Vegan (Baltimore: Vegetarian Resource Group, 2012) The AHA diet: given the AHA LF, Low-Cholesterol Cookbook (New York: Clarkson Potter, 2008) LDL-C: −0.09 (−0.27, 0.09) mmol/L; HbA1c: 0.00 (−0.13, 0.13) %
Toobert et al., 2000,128 USA 2 years, RCT, parallel arm Completed trial (1) Prime Time programme: very LF, LOV diet (17)
(2) Usual care (11)
Women with CHD; mean age: (1) 64 ± 10; (2) 63 ± 11 The reversal diet (very LF, LOV diet): no animal products other than egg whites and non-fat yogurt; no added oils or other concentrated fats; < 10% calories from fat Usual care LDL-C: −0.12 (−0.72, 0.48) mmol/L; SBP: −9.0 (−27.7, 9.7) mmHg
Cassidy et al., 2022,129 Australia 1 year, RCT, parallel arm ACTRN12620001151921; recruiting (1) Intensive lifestyle programme (75)
(2) AHA diet (75)
Individuals with CHD aged 18–80 years The 5:2 pesco-vegetarian diet: no animal foods other than fish, egg, and dairy products; 2 non-consecutive fasting days per week The AHA diet: general dietary guidelines from the AHA NA

CI, confidence interval; CHD, coronary heart disease; CR, calorie-restricted; F & V, fruits and vegetables; LDL-C, low-density lipoprotein cholesterol; LF, low-fat; LOV, lacto-ovo vegetarian diet; MD, mean differences; RCT, randomized controlled trial; SBP, systolic blood pressure; AHA, American Heart Association; HbA1c, haemoglobin A1c; IQR, interquartile range; NA, not applicable.

Cancer

To our knowledge, only one randomized clinical trial to date has investigated the effects of a vegan diet on cancer outcomes, and preliminary data show a significant reduction in body weight and cholesterol at 8 weeks.130  Table 3 summarizes the ongoing interventional clinical trials on the effects of vegetarian diets in people with cancer.

Table 3.

Study characteristics of clinical trials in people with cancer

Author, year, country Study design; intervention duration Registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description Relevant biomarkers (MD)
The vegetarian diet Comparison
Campbell et al., 2022,130 USA Randomized trial, parallel arms; 8 weeks NCT03045289 (1) WFPBD + multivitamin (19)
(2) Usual diet + multivitamin (9)
Women age ≥18 years with metastatic breast cancer A WHPBD: provide 3 meals/d; no animal products, refined flours; encourage fruits and vegetables A usual diet + daily multivitamin Final value (adjusted for baseline): weight (kg): (1) 73; (2) 77; P < .01
LDL-C (mmol/L): (1) 2.1; (2) 2.76; P < .01
SBP (mmHg): (1) 108.5; (2) 114.8; P = .06
CA 27.29 (U/mL): (1) 24.4; (2) 27.7; P = .09
Gulley et al., 2021,131 USA RCT, parallel arms; 16 weeks NCT04866810; recruiting (1) High-fibre PBD + exercise prescription (40)
(2) Standard diet + exercise guidelines (40)
Age ≥18 years with histologically or cytologically confirmed unresectable melanoma A high-fibre PBD: ideally a vegan diet, provided a sample meal plan and vegan recipes; ≥30 g fibre/d Standard diet from healthy eating guidelines NA
Author, year, country Study design; Intervention duration Registration number; status Study arms, sample size Population condition, gender, mean age (years) Diet description
The vegetarian diet Comparison
Jeppsen et al., 2022,132 USA, India Randomized trial, parallel arms; 12 weeks NCT05410002; active, not recruiting (1) Vegetarian + N-111
(2) Non-vegetarian + N-111
(3) Vegetarian + placebo
(4) Non-vegetarian + placebo
(5) Vegetarian control
(6) Non-vegetarian control
Age ≥ 25, < 80 years with positive diagnosis of breast or prostate cancer Vegetarian diet Usual diet
Iyengar et al., 2020,133 USA Randomized trial, parallel arms; 8 weeks NCT04298086; recruiting (1) CR vegetarian diet (31)
(2) Nutrition + physical activity counselling (31)
Overweight post-menopausal women with breast cancer A vegetarian diet: provide lunch + dinner for 6 d/week; no animal products; structured exercise A home-based, physical activity programme and nutrition counselling
Avivi et al., 2021,134 Israel Single-arm clinical trial; 3 years NCT04957693; recruiting Vegan diet and lifestyle changes (40) Age ≥18 years with diagnosis of indolent lymphoma Specifically designed vegan nutrition, physical activity (mostly aerobic), and stress reduction Not applicable
Shah et al., 2021,135 USA Single-arm clinical trial; 24 weeks NCT04920084; recruiting WFPBD (20) Age ≥18 years with smoldering multiple myeloma or MGUS A WHPBD: provide lunch + dinner for 6 d/week; no/minimal animal products; access to a coach daily Not applicable

LDL-C, low-density lipoprotein cholesterol; MD, mean differences; NA, not applicable; SBP, systolic blood pressure; WFPBD, whole-food plant-based diet; CR, calorie-restricted; MGUS, monoclonal gammopathy of undetermined significance; N-111, nutraceutical supplement, ingredients unspecified.

Dementia

To the best of our knowledge, no randomized clinical trials to date have investigated the effects of vegetarian or vegan diets on cognitive impairment or dementia outcomes. Our search of ongoing randomized clinical trials identified only one study testing the effects of a low-fat vegan diet on dementia (NCT04606420).

Potential health risks of vegan and vegetarian diets

Accumulating evidence indicate that some vegetarians, especially vegans who are consuming restrictive diets, are at greater risk of developing haemorrhagic stroke, bone fractures, and a range of vitamin and mineral deficiencies that are particularly dangerous for growing children and pregnant and breastfeeding women.136,137 Vitamin B12, for example, is an essential vitamin produced by specific strains of soil bacteria that animals ingest when grazing grass. During digestion, large amounts of vitamin B12 are formed and incorporated in the animal’s meat, milk, and eggs. Fish and shellfish also contain considerable amount of vitamin B12; for instance, 100 g of clams contain up to 49 µg of vitamin B12. People following strict vegan diets must take a vitamin B12 supplement and/or consume foods supplemented with vitamin B12, including vitamin B12–fortified nutritional yeast, to avoid developing megaloblastic anaemia, a potentially irreversible form of neuropathy, and impaired bone formation. Vitamin B12 in spirulina or other algae is not bioavailable and may even inhibit vitamin B12 metabolism,136 but vitamin B12 in duckweed is bioavailable.138 Other potential deficiencies that vegetarians may develop are those from iron and zinc and occasionally riboflavin.139 These deficiencies are especially important in vegan children, pregnant/breastfeeding women, and those with menorrhagia. Many plant foods contain iron and zinc, but their bioavailability is limited due plant anti-nutrients, such as phytates, tannins, lectins, and oxalates. Cooking, sprouting, fermenting, and processing plant foods with vitamin C rich foods can increase iron and zinc absorption.140 Dietary calcium deficiency especially when coupled with protein restriction and excessive sodium intake can increase the risk of bone fractures in ethical vegans who do not consume healthy diets rich in calcium- and protein-rich plant foods.93,137,141–143 Many plants contain calcium, and in some of these, its bioavailability is very high. For instance, 40%–60% of the calcium contained in cabbage, broccoli, or broccoli sprouts is absorbed because of their low oxalate content, against only 31%–32% of the calcium in cow’s milk.144 Legumes, soy products (especially tofu made with calcium sulphate), and figs are also excellent sources of dietary calcium and protein. Regular exercise training, adequate sun exposure, and vitamin D supplementation are also important to promote bone health and prevent fractures145 and may play a key role in the protection against certain autoimmune diseases and advanced (metastatic) cancers.146,147

The importance of consuming healthy vegetarian diets

Vegetarians should pay close attention to the quality and composition of their diets. Data from epidemiological studies suggest that men and women consuming plant-based diets rich in healthier plant foods (fresh vegetables, legumes, minimally processed whole grains, fruits, nuts, monounsaturated-rich vegetable oils, tea, and coffee) have lower risks of CHD and overall mortality with regular fish intake providing additionally health benefits.4,87,148–150 In contrast, people eating ‘unhealthy’ plant-based diets that emphasize refined grains, potatoes, high-sodium preserved vegetables, fried goods, sweets, juices, and sweetened beverages experienced higher risk of CHD and mortality.4,5 Similar results have been found for T2DM.5 Plant-based food products marketed as vegetarian and/or vegan can be rich in refined starch, added sugar, HFCS, salt, partially hydrogenated (trans) fat, and saturated fatty acids from tropical oils (e.g. one tablespoon of coconut oil contains 12 grams of saturated fat). Consumption of ultra-processed foods rich in sucrose and in HFCS, even if labelled as ‘vegetarian’ or ‘vegan’, promotes the development of insulin resistance, cardiometabolic syndrome, fatty liver disease, CVD, and cancer.151,152 High salt intake not only increases the risk of developing hypertension, CHD, and stroke,55,153 but it also triggers inflammation by increasing monocyte CCR2 expression.154  Trans-fatty acids from partially hydrogenated oils have markedly adverse effects on serum lipids, systemic inflammation, endothelial function, and ultimately on the risk of developing T2DM and CVD.155 However, naturally occurring trans-fatty acids found in milk and meat of ruminant animals have also similar adverse effects on LDL cholesterol, total cholesterol to HDL cholesterol ratio, and apolipoprotein B levels as do industrially produced trans-fatty acids.156 Finally, people consuming unhealthy vegetarian diets rich in refined carbohydrates might also be at risk of protein malnutrition. Plant foods contain all the nine essential amino acids but in different proportions. Legumes, for instance, are high in lysine, but low in tryptophan and methionine. In contrast, whole grains are low in lysine but high in tryptophan and methionine. Therefore, it is essential to consume every day a mixture of whole grains, beans and nuts, and/or protein-rich plant foods (e.g. tofu and mankai, a cultivated strain of the Wolffia globosa aquatic plant) to provide adequate amounts of all the essential and non-essential amino acids.

Conclusions

Consuming vegetarian diets rich in minimally processed plant foods has been associated with a reduced risk of developing multiple chronic diseases including CVD, diabetes, hypertension, cancer, and dementia. Data from randomized clinic trials have confirmed a protective effect of vegetarian diets for the prevention of diabetes, hypercholesterolaemia, hypertension, and overweight, but to date, no data are available for acute coronary syndrome, heart failure, stroke, cognitive impairment, and dementia, and there are very limited data for cancer. However, since many individuals commonly and increasingly adopt vegetarian diets worldwide for ideological, cultural, environmental, and personal factors, it is of paramount importance to define which vegetarian dietary compositions provide better health outcomes and which components are detrimental to human health (Graphical Abstract).

New randomized trials are needed to understand whether the advantages of healthy plant-based diets represent an all-or-nothing phenomenon and if consuming less strict plant-based diets containing small quantities of animal products (e.g. pescatarian or traditional Mediterranean diets) has beneficial or detrimental effect on specific health outcomes, including the prevention of haemorrhagic stroke and bone fracture. Further, mechanistic studies are warranted to enhance our understanding about healthy plant-based food patterns and the biological mechanisms linking dietary factors and chronic diseases.

Recommendations for clinicians and allied health practitioners

For overweight men and women seeking weight loss and cardiometabolic improvement as means of primary and secondary prevention of T2DM, hypertension, and CVD, well-balanced and supplemented vegetarian diets rich in minimally processed plant foods may be an option, especially when coupled with calorie restriction and regular exercise training as recommended in the 2018 Physical Activity Guidelines Advisory Committee Scientific Report.28,157 Regular fish intake can provide additional cardiovascular health benefits.158 Additional trials are warranted to determine whether patients with CVD will ultimately benefit from consuming vegetarian and vegan diets and, if so, in what ways. As with any potential therapeutic strategy, the risks and benefits of vegetarian diets must be discussed with patients. There is evidence to suggest that some vegetarians, particularly those who follow restrictive diets such as vegans, may be at greater risk of haemorrhagic stroke and bone fractures if they do not carefully plan their diets and consume fortified plant-based foods or supplements. In addition, vegans and some vegetarians may be at risk of deficiencies in vitamins and minerals such as vitamin B12, riboflavin, iron, zinc, calcium, and omega-3 fatty acids. This can be particularly dangerous for pregnant and breastfeeding women and growing children, as these nutrients are crucial for foetal and child development. It is recommended that anyone considering a vegetarian or vegan diet consult with a registered dietitian or healthcare provider to ensure that their diet is nutritionally adequate. Consuming vegetarian diets rich in refined grains, potatoes, high-sodium preserved vegetables, fried goods, sweets, juices, and sweetened beverages can increase the risk of developing T2DM and CVD morbidity and mortality. Finally, in the case of vegetarian diets and cancer, the benefits and risks are not well defined. As a weight loss strategy, this may be an option for some cancer patients, but there are currently no data to suggest that vegetarian or vegan diets in the absence of weight loss and/or changes in physical activity patterns will have a positive impact on cancer outcomes, including either recurrence or the development of metastatic cancers.

Supplementary data

Supplementary data are not available at European Heart Journal online.

Declarations

Disclosure of Interest

All authors declare no conflict of interest for this contribution.

Contributor Information

Tian Wang, Charles Perkins Center, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Andrius Masedunskas, Charles Perkins Center, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Walter C Willett, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.

Luigi Fontana, Charles Perkins Center, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Department of Clinical and Experimental Sciences, Brescia University, Brescia, Lombardy, Italy.

Data Availability

Most extracted data and study materials are available from previously published research. Additional data extracted from the corresponding author of included studies will be shared upon reasonable request.

Funding

L.F. is supported by grants from the Australian National Health and Medical Research Council’s Investigator Grant (APP1177797), Australian Youth and Health Foundation, and Philip Bushell Foundation. W.W. is supported by grants from the National Institutes of Health on the epidemiology of cancer.

References

  • 1. Willett  W, Rockstrom  J, Loken  B, Springmann  M, Lang  T, Vermeulen  S, et al.  Food in the anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet  2019;393:447–92. 10.1016/S0140-6736(18)31788-4 [DOI] [PubMed] [Google Scholar]
  • 2. Sievenpiper  JL, Chan  CB, Dworatzek  PD, Freeze  C, Williams  SL. Nutrition therapy. Can J Diabetes  2018;42:S64–79. 10.1016/j.jcjd.2017.10.009 [DOI] [PubMed] [Google Scholar]
  • 3. Melina  V, Craig  W, Levin  S. Position of the academy of nutrition and dietetics: vegetarian diets. J Acad Nutr Diet  2016;116:1970–80. 10.1016/j.jand.2016.09.025 [DOI] [PubMed] [Google Scholar]
  • 4. Satija  A, Bhupathiraju  SN, Spiegelman  D, Chiuve  SE, Manson  JE, Willett  W, et al.  Healthful and unhealthful plant-based diets and the risk of coronary heart disease in U.S. adults. J Am Coll Cardiol  2017;70:411–22. 10.1016/j.jacc.2017.05.047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Satija  A, Bhupathiraju  SN, Rimm  EB, Spiegelman  D, Chiuve  SE, Borgi  L, et al.  Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies. PLoS Med  2016;13:e1002039. 10.1371/journal.pmed.1002039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Wang  F, Ugai  T, Haruki  K, Wan  Y, Akimoto  N, Arima  K, et al.  Healthy and unhealthy plant-based diets in relation to the incidence of colorectal cancer overall and by molecular subtypes. Clin Transl Med  2022;12:e893. 10.1002/ctm2.893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Sacks  FM, Lichtenstein  AH, Wu  JHY, Appel  LJ, Creager  MA, Kris-Etherton  PM, et al.  Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation  2017;136:e1–e23. 10.1161/CIR.0000000000000510 [DOI] [PubMed] [Google Scholar]
  • 8. Mensink  RP, Zock  PL, Kester  AD, Katan  MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr  2003;77:1146–55. 10.1093/ajcn/77.5.1146 [DOI] [PubMed] [Google Scholar]
  • 9. Li  Y, Hruby  A, Bernstein  AM, Ley  SH, Wang  DD, Chiuve  SE, et al.  Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study. J Am Coll Cardiol  2015;66:1538–48. 10.1016/j.jacc.2015.07.055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Dayton  S, Pearce  ML, Goldman  H, Harnish  A, Plotkin  D, Shickman  M, et al.  Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet  1968;2:1060–2. 10.1016/S0140-6736(68)91531-6 [DOI] [PubMed] [Google Scholar]
  • 11. Leren  P. The Oslo diet-heart study. Eleven-year report. Circulation  1970;42:935–42. 10.1161/01.CIR.42.5.935 [DOI] [PubMed] [Google Scholar]
  • 12. Turpeinen  O. Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Circulation  1979;59:1–7. 10.1161/01.CIR.59.1.1 [DOI] [PubMed] [Google Scholar]
  • 13. Mihaylova  B, Emberson  J, Blackwell  L, Keech  A, Simes  J, Barnes  EH, et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet  2012;380:581–90. 10.1016/S0140-6736(12)60367-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kris-Etherton  PM, Hecker  KD, Bonanome  A, Coval  SM, Binkoski  AE, Hilpert  KF, et al.  Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med  2002;113:71s–88s. 10.1016/S0002-9343(01)00995-0 [DOI] [PubMed] [Google Scholar]
  • 15. Hu  FB, Stampfer  MJ, Manson  JE, Rimm  EB, Colditz  GA, Rosner  BA, et al.  Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ  1998;317:1341–5. 10.1136/bmj.317.7169.1341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Jenkins  DJ, Jones  PJ, Lamarche  B, Kendall  CW, Faulkner  D, Cermakova  L, et al.  Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA  2011;306:831–9. 10.1001/jama.2011.1202 [DOI] [PubMed] [Google Scholar]
  • 17. Salas-Salvado  J, Farres  X, Luque  X, Narejos  S, Borrell  M, Basora  J, et al.  Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Br J Nutr  2008;99:1380–7. 10.1017/S0007114507868528 [DOI] [PubMed] [Google Scholar]
  • 18. Abumweis  SS, Barake  R, Jones  PJ. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res  2008;52. 10.3402/fnr.v52i0.1811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Theuwissen  E, Mensink  RP. Water-soluble dietary fibers and cardiovascular disease. Physiol Behav  2008;94:285–92. 10.1016/j.physbeh.2008.01.001 [DOI] [PubMed] [Google Scholar]
  • 20. Orlich  MJ, Fraser  GE. Vegetarian diets in the Adventist Health Study 2: a review of initial published findings. Am J Clin Nutr  2014;100:353S–8S. 10.3945/ajcn.113.071233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Key  T, Davey  G. Prevalence of obesity is low in people who do not eat meat. BMJ  1996;313:816–7. 10.1136/bmj.313.7060.816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Sofi  F, Dinu  M, Pagliai  G, Cesari  F, Gori  AM, Sereni  A, et al.  Low-calorie vegetarian versus Mediterranean diets for reducing body weight and improving cardiovascular risk profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet). Circulation  2018;137:1103–13. 10.1161/CIRCULATIONAHA.117.030088 [DOI] [PubMed] [Google Scholar]
  • 23. Gepner  Y, Shelef  I, Schwarzfuchs  D, Zelicha  H, Tene  L, Yaskolka Meir  A, et al.  Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial. Circulation  2018;137:1143–57. 10.1161/CIRCULATIONAHA.117.030501 [DOI] [PubMed] [Google Scholar]
  • 24. Müller  M, Canfora  EE, Blaak  EE. Gastrointestinal transit time, glucose homeostasis and metabolic health: modulation by dietary fibers. Nutrients  2018;10:275. 10.3390/nu10030275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Cani  PD, Delzenne  NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des  2009;15:1546–58. 10.2174/138161209788168164 [DOI] [PubMed] [Google Scholar]
  • 26. Alkhezi  OS, Alahmed  AA, Alfayez  OM, Alzuman  OA, Almutairi  AR, Almohammed  OA. Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials. Obes Rev  2023;24:e13543. 10.1111/obr.13543 [DOI] [PubMed] [Google Scholar]
  • 27. Marx  N, Husain  M, Lehrke  M, Verma  S, Sattar  N. GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes. Circulation  2022;146:1882–94. 10.1161/CIRCULATIONAHA.122.059595 [DOI] [PubMed] [Google Scholar]
  • 28. Green  CL, Lamming  DW, Fontana  L. Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol  2022;23:56–73. 10.1038/s41580-021-00411-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Weiss  EP, Racette  SB, Villareal  DT, Fontana  L, Steger-May  K, Schechtman  KB, et al.  Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr  2006;84:1033–42. 10.1093/ajcn/84.5.1033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Kraus  WE, Bhapkar  M, Huffman  KM, Pieper  CF, Krupa Das  S, Redman  LM, et al.  2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol  2019;7:673–83. 10.1016/S2213-8587(19)30151-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Clifton  KK, Ma  CX, Fontana  L, Peterson  LL. Intermittent fasting in the prevention and treatment of cancer. CA Cancer J Clin  2021;71:527–46. 10.3322/caac.21694 [DOI] [PubMed] [Google Scholar]
  • 32. Mittendorfer  B, Klein  S, Fontana  L. A word of caution against excessive protein intake. Nat Rev Endocrinol  2020;16:59–66. 10.1038/s41574-019-0274-7 [DOI] [PubMed] [Google Scholar]
  • 33. Tinker  LF, Sarto  GE, Howard  BV, Huang  Y, Neuhouser  ML, Mossavar-Rahmani  Y, et al.  Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women’s Health Initiative. Am J Clin Nutr  2011;94:1600–6. 10.3945/ajcn.111.018648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Sluijs  I, Beulens  JW, van der A  DL, Spijkerman  AM, Grobbee  DE, van der Schouw  YT. Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL study. Diabetes Care  2010;33:43–8. 10.2337/dc09-1321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Malik  VS, Li  Y, Tobias  DK, Pan  A, Hu  FB. Dietary protein intake and risk of type 2 diabetes in US men and women. Am J Epidemiol  2016;183:715–28. 10.1093/aje/kwv268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Smith  GI, Yoshino  J, Kelly  SC, Reeds  DN, Okunade  A, Patterson  BW, et al.  High-protein intake during weight loss therapy eliminates the weight-loss-induced improvement in insulin action in obese postmenopausal women. Cell Rep  2016;17:849–61. 10.1016/j.celrep.2016.09.047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Fontana  L, Cummings  NE, Apelo  SIA, Neuman  JC, Kasza  I, Schmidt  BA, et al.  Decreased consumption of branched-chain amino acids improves metabolic health. Cell Rep  2016;16:520–30. 10.1016/j.celrep.2016.05.092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Xu  Y, Jiang  H, Li  L, Chen  F, Liu  Y, Zhou  M, et al.  Branched-chain amino acid catabolism promotes thrombosis risk by enhancing tropomodulin-3 propionylation in platelets. Circulation  2020;142:49–64. 10.1161/CIRCULATIONAHA.119.043581 [DOI] [PubMed] [Google Scholar]
  • 39. Weickert  MO, Roden  M, Isken  F, Hoffmann  D, Nowotny  P, Osterhoff  M, et al.  Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr  2011;94:459–71. 10.3945/ajcn.110.004374 [DOI] [PubMed] [Google Scholar]
  • 40. Hattersley  JG, Pfeiffer  AF, Roden  M, Petzke  KJ, Hoffmann  D, Rudovich  NN, et al.  Modulation of amino acid metabolic signatures by supplemented isoenergetic diets differing in protein and cereal fiber content. J Clin Endocrinol Metab  2014;99:E2599–609. 10.1210/jc.2014-2302 [DOI] [PubMed] [Google Scholar]
  • 41. Sargrad  KR, Homko  C, Mozzoli  M, Boden  G. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus. J Am Diet Assoc  2005;105:573–80. 10.1016/j.jada.2005.01.009 [DOI] [PubMed] [Google Scholar]
  • 42. Zhang  X, Sergin  I, Evans  TD, Jeong  SJ, Rodriguez-Velez  A, Kapoor  D, et al.  High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy. Nat Metab  2020;2:110–25. 10.1038/s42255-019-0162-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Howitz  KT, Sinclair  DA. Xenohormesis: sensing the chemical cues of other species. Cell  2008;133:387–91. 10.1016/j.cell.2008.04.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Liguori  I, Russo  G, Curcio  F, Bulli  G, Aran  L, Della-Morte  D, et al.  Oxidative stress, aging, and diseases. Clin Interv Aging  2018;13:757–72. 10.2147/CIA.S158513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Fito  M, Guxens  M, Corella  D, Saez  G, Estruch  R, de la Torre  R, et al.  Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med  2007;167:1195–203. 10.1001/archinte.167.11.1195 [DOI] [PubMed] [Google Scholar]
  • 46. Björkegren  JLM, Lusis  AJ. Atherosclerosis: recent developments. Cell  2022;185:1630–45. 10.1016/j.cell.2022.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Li  J, Lee  DH, Hu  J, Tabung  FK, Li  Y, Bhupathiraju  SN, et al.  Dietary inflammatory potential and risk of cardiovascular disease among men and women in the U.S. J Am Coll Cardiol  2020;76:2181–93. 10.1016/j.jacc.2020.09.535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Hajihashemi  P, Haghighatdoost  F. Effects of whole-grain consumption on selected biomarkers of systematic inflammation: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Nutr  2019;38:275–85. 10.1080/07315724.2018.1490935 [DOI] [PubMed] [Google Scholar]
  • 49. Hosseini  B, Berthon  BS, Saedisomeolia  A, Starkey  MR, Collison  A, Wark  PAB, et al.  Effects of fruit and vegetable consumption on inflammatory biomarkers and immune cell populations: a systematic literature review and meta-analysis. Am J Clin Nutr  2018;108:136–55. 10.1093/ajcn/nqy082 [DOI] [PubMed] [Google Scholar]
  • 50. Hosseinpour-Niazi  S, Mirmiran  P, Fallah-Ghohroudi  A, Azizi  F. Non-soya legume-based therapeutic lifestyle change diet reduces inflammatory status in diabetic patients: a randomised cross-over clinical trial. Br J Nutr  2015;114:213–9. 10.1017/S0007114515001725 [DOI] [PubMed] [Google Scholar]
  • 51. Aeberli  I, Gerber  PA, Hochuli  M, Kohler  S, Haile  SR, Gouni-Berthold  I, et al.  Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr  2011;94:479–85. 10.3945/ajcn.111.013540 [DOI] [PubMed] [Google Scholar]
  • 52. Hematdar  Z, Ghasemifard  N, Phishdad  G, Faghih  S. Substitution of red meat with soybean but not non- soy legumes improves inflammation in patients with type 2 diabetes; a randomized clinical trial. J Diabetes Metab Disord  2018;17:111–6. 10.1007/s40200-018-0346-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Sacks  FM, Svetkey  LP, Vollmer  WM, Appel  LJ, Bray  GA, Harsha  D, et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med  2001;344:3–10. 10.1056/NEJM200101043440101 [DOI] [PubMed] [Google Scholar]
  • 54. Neter  JE, Stam  BE, Kok  FJ, Grobbee  DE, Geleijnse  JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension  2003;42:878–84. 10.1161/01.HYP.0000094221.86888.AE [DOI] [PubMed] [Google Scholar]
  • 55. Neal  B, Wu  Y, Feng  X, Zhang  R, Zhang  Y, Shi  J, et al.  Effect of salt substitution on cardiovascular events and death. N Engl J Med  2021;385:1067–77. 10.1056/NEJMoa2105675 [DOI] [PubMed] [Google Scholar]
  • 56. Whelton  SP, Chin  A, Xin  X, He  J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med  2002;136:493–503. 10.7326/0003-4819-136-7-200204020-00006 [DOI] [PubMed] [Google Scholar]
  • 57. Livingston  G, Huntley  J, Sommerlad  A, Ames  D, Ballard  C, Banerjee  S, et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet  2020;396:413–46. 10.1016/S0140-6736(20)30367-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Schiffrin  EL, Engert  JC. Hypertension, brain imaging phenotypes, and cognitive impairment: lessons from Mendelian randomization. Eur Heart J  2023;44:2126–8. 10.1093/eurheartj/ehad187 [DOI] [PubMed] [Google Scholar]
  • 59. Hughes  D, Judge  C, Murphy  R, Loughlin  E, Costello  M, Whiteley  W, et al.  Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis. JAMA  2020;323:1934–44. 10.1001/jama.2020.4249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Muegge  BD, Kuczynski  J, Knights  D, Clemente  JC, González  A, Fontana  L, et al.  Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science  2011;332:970–4. 10.1126/science.1198719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Thorburn  AN, Macia  L, Mackay  CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity  2014;40:833–42. 10.1016/j.immuni.2014.05.014 [DOI] [PubMed] [Google Scholar]
  • 62. Wang  Z, Bergeron  N, Levison  BS, Li  XS, Chiu  S, Jia  X, et al.  Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J  2018;40:583–94. 10.1093/eurheartj/ehy799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Koeth  RA, Lam-Galvez  BR, Kirsop  J, Wang  Z, Levison  BS, Gu  X, et al.  l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J Clin Invest  2019;129:373–87. 10.1172/JCI94601 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Tang  WH, Wang  Z, Levison  BS, Koeth  RA, Britt  EB, Fu  X, et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med  2013;368:1575–84. 10.1056/NEJMoa1109400 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Li  XS, Obeid  S, Klingenberg  R, Gencer  B, Mach  F, Räber  L, et al.  Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J  2017;38:814–24. 10.1093/eurheartj/ehw582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Dietrich  S, Trefflich  I, Ueland  PM, Menzel  J, Penczynski  KJ, Abraham  K, et al.  Amino acid intake and plasma concentrations and their interplay with gut microbiota in vegans and omnivores in Germany. Eur J Nutr  2022;61:2103–14. 10.1007/s00394-021-02790-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Losno  EA, Sieferle  K, Perez-Cueto  FJA, Ritz  C. Vegan diet and the gut microbiota composition in healthy adults. Nutrients  2021;13:2402. 10.3390/nu13072402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Kasahara  K, Krautkramer  KA, Org  E, Romano  KA, Kerby  RL, Vivas  EI, et al.  Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol  2018;3:1461–71. 10.1038/s41564-018-0272-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Sonnenburg  ED, Smits  SA, Tikhonov  M, Higginbottom  SK, Wingreen  NS, Sonnenburg  JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature  2016;529:212–5. 10.1038/nature16504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Mazmanian  SK, Liu  CH, Tzianabos  AO, Kasper  DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell  2005;122:107–18. 10.1016/j.cell.2005.05.007 [DOI] [PubMed] [Google Scholar]
  • 71. Tsaban  G, Yaskolka Meir  A, Rinott  E, Zelicha  H, Kaplan  A, Shalev  A, et al.  The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial. Heart  2020;107:heartjnl-2020-317802. 10.1136/heartjnl-2020-317802 [DOI] [PubMed] [Google Scholar]
  • 72. Rinott  E, Meir  AY, Tsaban  G, Zelicha  H, Kaplan  A, Knights  D, et al.  The effects of the green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial. Genome Med  2022;14:29. 10.1186/s13073-022-01015-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Griffin  NW, Ahern  PP, Cheng  J, Heath  AC, Ilkayeva  O, Newgard  CB, et al.  Prior dietary practices and connections to a human gut microbial metacommunity alter responses to diet interventions. Cell Host Microbe  2017;21:84–96. 10.1016/j.chom.2016.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Dey  N, Wagner  VE, Blanton  LV, Cheng  J, Fontana  L, Haque  R, et al.  Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell  2015;163:95–107. 10.1016/j.cell.2015.08.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Sacks  FM, Kass  EH. Low blood pressure in vegetarians: effects of specific foods and nutrients. Am J Clin Nutr  1988;48:795–800. 10.1093/ajcn/48.3.795 [DOI] [PubMed] [Google Scholar]
  • 76. Beilin  LJ, Rouse  IL, Armstrong  BK, Margetts  BM, Vandongen  R. Vegetarian diet and blood pressure levels: incidental or causal association?  Am J Clin Nutr  1988;48:806–10. 10.1093/ajcn/48.3.806 [DOI] [PubMed] [Google Scholar]
  • 77. Borgi  L, Curhan  GC, Willett  WC, Hu  FB, Satija  A, Forman  JP. Long-term intake of animal flesh and risk of developing hypertension in three prospective cohort studies. J Hypertension  2015;33:2231–8. 10.1097/HJH.0000000000000722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Tonstad  S, Stewart  K, Oda  K, Batech  M, Herring  RP, Fraser  GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis  2013;23:292–9. 10.1016/j.numecd.2011.07.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Vang  A, Singh  PN, Lee  JW, Haddad  EH, Brinegar  CH. Meats, processed meats, obesity, weight gain and occurrence of diabetes among adults: findings from Adventist health studies. Ann Nutr Metab  2008;52:96–104. 10.1159/000121365 [DOI] [PubMed] [Google Scholar]
  • 80. Pan  A, Sun  Q, Bernstein  AM, Manson  JE, Willett  WC, Hu  FB. Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. JAMA Intern Med  2013;173:1328–35. 10.1001/jamainternmed.2013.6633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Key  TJ, Fraser  GE, Thorogood  M, Appleby  PN, Beral  V, Reeves  G, et al.  Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr  1999;70:516S–24S. 10.1093/ajcn/70.3.516s [DOI] [PubMed] [Google Scholar]
  • 82. Huang  T, Yang  B, Zheng  J, Li  G, Wahlqvist  ML, Li  D. Cardiovascular disease mortality and cancer incidence in vegetarians: a meta-analysis and systematic review. Ann Nutr Metab  2012;60:233–40. 10.1159/000337301 [DOI] [PubMed] [Google Scholar]
  • 83. Crowe  FL, Appleby  PN, Travis  RC, Key  TJ. Risk of hospitalization or death from ischemic heart disease among British vegetarians and nonvegetarians: results from the EPIC-Oxford cohort study. Am J Clin Nutr  2013;97:597–603. 10.3945/ajcn.112.044073 [DOI] [PubMed] [Google Scholar]
  • 84. Kwok  CS, Umar  S, Myint  PK, Mamas  MA, Loke  YK. Vegetarian diet, Seventh Day Adventists and risk of cardiovascular mortality: a systematic review and meta-analysis. Int J Cardiol  2014;176:680–6. 10.1016/j.ijcard.2014.07.080 [DOI] [PubMed] [Google Scholar]
  • 85. Key  TJ, Appleby  PN, Spencer  EA, Travis  RC, Roddam  AW, Allen  NE. Mortality in British vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford). Am J Clin Nutr  2009;89:S1613–S9. 10.3945/ajcn.2009.26736L [DOI] [PubMed] [Google Scholar]
  • 86. Appleby  PN, Crowe  FL, Bradbury  KE, Travis  RC, Key  TJ. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom. Am J Clin Nutr  2016;103:218–30. 10.3945/ajcn.115.119461 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Petermann-Rocha  F, Parra-Soto  S, Gray  S, Anderson  J, Welsh  P, Gill  J, et al.  Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank. Eur Heart J  2020;42:1136–43. 10.1093/eurheartj/ehaa939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Chang-Claude  J, Hermann  S, Eilber  U, Steindorf  K. Lifestyle determinants and mortality in German vegetarians and health-conscious persons: results of a 21-year follow-up. Cancer Epidemiol Biomarkers Prev  2005;14:963–8. 10.1158/1055-9965.EPI-04-0696 [DOI] [PubMed] [Google Scholar]
  • 89. Baden  MY, Liu  G, Satija  A, Li  Y, Sun  Q, Fung  TT, et al.  Changes in plant-based diet quality and total and cause-specific mortality. Circulation  2019;140:979–91. 10.1161/CIRCULATIONAHA.119.041014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Appel  LJ, Brands  MW, Daniels  SR, Karanja  N, Elmer  PJ, Sacks  FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension  2006;47:296–308. 10.1161/01.HYP.0000202568.01167.B6 [DOI] [PubMed] [Google Scholar]
  • 91. Oussalah  A, Levy  J, Berthezène  C, Alpers  DH, Guéant  JL. Health outcomes associated with vegetarian diets: an umbrella review of systematic reviews and meta-analyses. Clin Nutr  2020;39:3283–307. 10.1016/j.clnu.2020.02.037 [DOI] [PubMed] [Google Scholar]
  • 92. Wang  F, Zheng  J, Yang  B, Jiang  J, Fu  Y, Li  D. Effects of vegetarian diets on blood lipids: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc  2015;4:e002408. 10.1161/JAHA.115.002408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Key  TJ, Papier  K, Tong  TYN. Plant-based diets and long-term health: findings from the EPIC-Oxford study. Proc Nutr Soc  2022;81:190–8. 10.1017/S0029665121003748 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Parra-Soto  S, Ahumada  D, Petermann-Rocha  F, Boonpoor  J, Gallegos  JL, Anderson  J, et al.  Association of meat, vegetarian, pescatarian and fish-poultry diets with risk of 19 cancer sites and all cancer: findings from the UK Biobank prospective cohort study and meta-analysis. BMC Med  2022;20:79. 10.1186/s12916-022-02257-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Key  TJ, Appleby  PN, Crowe  FL, Bradbury  KE, Schmidt  JA, Travis  RC. Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr  2014;100:378S–85S. 10.3945/ajcn.113.071266 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Gilsing  AM, Weijenberg  MP, Goldbohm  RA, Dagnelie  PC, van den Brandt  PA, Schouten  LJ. Vegetarianism, low meat consumption and the risk of lung, postmenopausal breast and prostate cancer in a population-based cohort study. Eur J Clin Nutr  2016;70:723–9. 10.1038/ejcn.2016.25 [DOI] [PubMed] [Google Scholar]
  • 97. Cade  JE, Taylor  EF, Burley  VJ, Greenwood  DC. Common dietary patterns and risk of breast cancer: analysis from the United Kingdom Women’s Cohort Study. Nutr Cancer  2010;62:300–6. 10.1080/01635580903441246 [DOI] [PubMed] [Google Scholar]
  • 98. Penniecook-Sawyers  JA, Jaceldo-Siegl  K, Fan  J, Beeson  L, Knutsen  S, Herring  P, et al.  Vegetarian dietary patterns and the risk of breast cancer in a low-risk population. Br J Nutr  2016;115:1790–7. 10.1017/S0007114516000751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Tantamango-Bartley  Y, Knutsen  SF, Knutsen  R, Jacobsen  BK, Fan  J, Beeson  WL, et al.  Are strict vegetarians protected against prostate cancer?  Am J Clin Nutr  2016;103:153–60. 10.3945/ajcn.114.106450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Heaney  RP, McCarron  DA, Dawson-Hughes  B, Oparil  S, Berga  SL, Stern  JS, et al.  Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc  1999;99:1228–33. 10.1016/S0002-8223(99)00302-8 [DOI] [PubMed] [Google Scholar]
  • 101. Iguacel  I, Huybrechts  I, Moreno  LA, Michels  N. Vegetarianism and veganism compared with mental health and cognitive outcomes: a systematic review and meta-analysis. Nutr Rev  2021;79:361–81. 10.1093/nutrit/nuaa030 [DOI] [PubMed] [Google Scholar]
  • 102. Tsai  JH, Huang  CF, Lin  MN, Chang  CE, Chang  CC, Lin  CL. Taiwanese vegetarians are associated with lower dementia risk: a prospective cohort study. Nutrients  2022;14:588. 10.3390/nu14030588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Yokoyama  Y, Nishimura  K, Barnard  ND, Takegami  M, Watanabe  M, Sekikawa  A, et al.  Vegetarian diets and blood pressure: a meta-analysis. JAMA Int Med  2014;174:577–87. 10.1001/jamainternmed.2013.14547 [DOI] [PubMed] [Google Scholar]
  • 104. Lopez  PD, Cativo  EH, Atlas  SA, Rosendorff  C. The effect of vegan diets on blood pressure in adults: a meta-analysis of randomized controlled trials. Am J Med  2019;132:875–83.e7. 10.1016/j.amjmed.2019.01.044 [DOI] [PubMed] [Google Scholar]
  • 105. Gibbs  J, Gaskin  E, Ji  C, Miller  MA, Cappuccio  FP. The effect of plant-based dietary patterns on blood pressure: a systematic review and meta-analysis of controlled intervention trials. J Hypertension  2021;39:23–37. 10.1097/HJH.0000000000002604 [DOI] [PubMed] [Google Scholar]
  • 106. Meyer  TE, Kovács  SJ, Ehsani  AA, Klein  S, Holloszy  JO, Fontana  L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol  2006;47:398–402. 10.1016/j.jacc.2005.08.069 [DOI] [PubMed] [Google Scholar]
  • 107. Xin  X, He  J, Frontini  MG, Ogden  LG, Motsamai  OI, Whelton  PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension  2001;38:1112–7. 10.1161/hy1101.093424 [DOI] [PubMed] [Google Scholar]
  • 108. Viguiliouk  E, Kendall  CW, Kahleová  H, Rahelić  D, Salas-Salvadó  J, Choo  VL, et al.  Effect of vegetarian dietary patterns on cardiometabolic risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr  2019;38:1133–45. 10.1016/j.clnu.2018.05.032 [DOI] [PubMed] [Google Scholar]
  • 109. Barnard  ND, Cohen  J, Jenkins  DJ, Turner-McGrievy  G, Gloede  L, Jaster  B, et al.  A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care  2006;29:1777–83. 10.2337/dc06-0606 [DOI] [PubMed] [Google Scholar]
  • 110. Lee  YM, Kim  SA, Lee  IK, Kim  JG, Park  KG, Jeong  JY, et al.  Effect of a brown rice based vegan diet and conventional diabetic diet on glycemic control of patients with type 2 diabetes: a 12-week randomized clinical trial. PLoS One  2016;11:e0155918. 10.1371/journal.pone.0155918 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Barnard  ND, Levin  SM, Gloede  L, Flores  R. Turning the waiting room into a classroom: weekly classes using a vegan or a portion-controlled eating plan improve diabetes control in a randomized translational study. J Acad Nutr Diet  2018;118:1072–9. 10.1016/j.jand.2017.11.017 [DOI] [PubMed] [Google Scholar]
  • 112. Bunner  AE, Wells  CL, Gonzales  J, Agarwal  U, Bayat  E, Barnard  ND. A dietary intervention for chronic diabetic neuropathy pain: a randomized controlled pilot study. Nutr Diabetes  2015;5:e158. 10.1038/nutd.2015.8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Kahleova  H, Matoulek  M, Malinska  H, Oliyarnik  O, Kazdova  L, Neskudla  T, et al.  Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with type 2 diabetes. Diabet Med  2011;28:549–59. 10.1111/j.1464-5491.2010.03209.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Lee  YM, Kim  SA, Lee  IK, Kim  JG, Park  KG, Jeong  JY, et al.  Effect of a brown rice based vegan diet and conventional diabetic diet on glycemic control of patients with type 2 diabetes: a 12-week randomized clinical trial. PLoS One  2016;11:e0155918. 10.1371/journal.pone.0155918 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Nicholson  AS, Sklar  M, Barnard  ND, Gore  S, Sullivan  R, Browning  S. Toward improved management of NIDDM: a randomized, controlled, pilot intervention using a lowfat, vegetarian diet. Prev Med  1999;29:87–91. 10.1006/pmed.1999.0529 [DOI] [PubMed] [Google Scholar]
  • 116. Campbell  TM. Whole-Food, Plant-Based Nutrition Among Women With Metastatic Breast Cancer: A Pilot Study of Recruitment, Retention, and Preliminary Changes in Biomarkers and Symptoms: University of Rochester; 2018. [Google Scholar]
  • 117. Kahleova  H. Effect of a dietary intervention on intracellular lipid, insulin sensitivity, and glycemic control in type 2 diabetes. https://clinicaltrialsgov/show/NCT04088981. 2019.
  • 118. Wright  N. The EDGe (End Diabetes Gisborne) trial . Using the whole-foods, plant-based diet in a community programme for people with obesity and diabetes. 2017. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372452&isReview=true.
  • 119. Ornish  D, Scherwitz  LW, Billings  JH, Brown  SE, Gould  KL, Merritt  TA, et al.  Intensive lifestyle changes for reversal of coronary heart disease. JAMA  1998;280:2001–7. 10.1001/jama.280.23.2001 [DOI] [PubMed] [Google Scholar]
  • 120. Gould  KL, Ornish  D, Scherwitz  L, Brown  S, Edens  RP, Hess  MJ, et al.  Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA  1995;274:894–901. 10.1001/jama.1995.03530110056036 [DOI] [PubMed] [Google Scholar]
  • 121. Huang  RY, Huang  CC, Hu  FB, Chavarro  JE. Vegetarian diets and weight reduction: a meta-analysis of randomized controlled trials. J Gen Intern Med  2016;31:109–16. 10.1007/s11606-015-3390-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122. Yokoyama  Y, Levin  SM, Barnard  ND. Association between plant-based diets and plasma lipids: a systematic review and meta-analysis. Nutr Rev  2017;75:683–98. 10.1093/nutrit/nux030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123. Yokoyama  Y, Barnard  ND, Levin  SM, Watanabe  M. Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovasc Diagn Ther  2014;4:373–82. 10.3978/j.issn.2223-3652.2014.10.04 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124. Aldana  SG, Greenlaw  R, Salberg  A, Merrill  RM, Hager  R, Jorgensen  RB. The effects of an intensive lifestyle modification program on carotid artery intima-media thickness: a randomized trial. Am J Health Promot  2007;21:510–6. 10.4278/0890-1171-21.6.510 [DOI] [PubMed] [Google Scholar]
  • 125. Ornish  D, Brown  SE, Scherwitz  LW, Billings  JH, Armstrong  WT, Ports  TA, et al.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet  1990;336:129–33. 10.1016/0140-6736(90)91656-U [DOI] [PubMed] [Google Scholar]
  • 126. Shah  B, Ganguzza  L, Slater  J, Newman  JD, Allen  N, Fisher  E, et al.  The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: study design and rationale. Contemp Clin Trials Commun  2017;8:90–8. 10.1016/j.conctc.2017.09.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Shah  B, Newman  JD, Woolf  K, Ganguzza  L, Guo  Y, Allen  N, et al.  Anti-inflammatory effects of a vegan diet versus the American Heart Association-recommended diet in coronary artery disease trial. J Am Heart Assoc  2018;7:e011367. 10.1161/JAHA.118.011367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128. Toobert  DJ, Glasgow  RE, Radcliffe  JL. Physiologic and related behavioral outcomes from the Women’s Lifestyle Heart Trial. Ann Behav Med  2000;22:1–9. 10.1007/BF02895162 [DOI] [PubMed] [Google Scholar]
  • 129. Cassidy  S, Kroeger  CM, Wang  T, Mitra  S, Liu  C, Ribeiro  RV, et al.  Impact of an intensive lifestyle program on low attenuation plaque and myocardial perfusion in coronary heart disease: a randomised clinical trial protocol. Nutr Heal Aging  2022;7:9–22. 10.3233/NHA-210146 [DOI] [Google Scholar]
  • 130. Campbell  T, Campbell  E, Culakova  E, Janelsins  MC, Mustian  KM, Kamen  CS, et al.  A whole-food, plant-based (WFPB) dietary intervention to improve cancer-related and cardiometabolic outcomes in metastatic breast cancer patients. J Clin Oncol  2022;40:e24116. 10.1200/JCO.2022.40.16_suppl.e24116 [DOI] [Google Scholar]
  • 131. Gulley  JL. The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN): National Cancer Institute (NCI); 2023. [Google Scholar]
  • 132. Jeppsen  E. A Study on the Effect Diet Has Affecting the Response of Patients Taking N-111 Who Are on a Vegetarian Diet vs a Non-Vegetarian Diet or a Placebo: Optimal Health Research; 2022. [Google Scholar]
  • 133. Iyengar  N. Pharmacodynamic Response to Exercise Treatment and Plant-Based Diet in Overweight/Obese Postmenopausal Women With Primary Hormone Receptor Positive Breast Cancer: A Phase 2 Randomized Control Trial; 2020. [Google Scholar]
  • 134. Avivi  I. Effect of Vegan Diet and Lifestyle Changes on Indolent Lymphoma During Controlled Waiting Period: Tel-Aviv Sourasky Medical Center; 2021. [Google Scholar]
  • 135. Shah  U. A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM); 2021. [Google Scholar]
  • 136. Donaldson  MS. Metabolic vitamin B12 status on a mostly raw vegan diet with follow-up using tablets, nutritional yeast, or probiotic supplements. Ann Nutr Metab  2000;44:229–34. 10.1159/000046689 [DOI] [PubMed] [Google Scholar]
  • 137. Appleby  P, Roddam  A, Allen  N, Key  T. Comparative fracture risk in vegetarians and nonvegetarians in EPIC-Oxford. Eur J Clin Nutr  2007;61:1400–6. 10.1038/sj.ejcn.1602659 [DOI] [PubMed] [Google Scholar]
  • 138. Sela  I, Yaskolka Meir  A, Brandis  A, Krajmalnik-Brown  R, Zeibich  L, Chang  D, et al.  Wolffia globosa-mankai plant-based protein contains bioactive vitamin B(12) and is well absorbed in humans. Nutrients  2020;12:3067. 10.3390/nu12103067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139. Savva  SC, Kafatos  A. Is red meat required for the prevention of iron deficiency among children and adolescents?  Curr Pediatr Rev  2014;10:177–83. 10.2174/157339631130900008 [DOI] [PubMed] [Google Scholar]
  • 140. Manary  MJ, Krebs  NF, Gibson  RS, Broadhead  RL, Hambidge  KM. Community-based dietary phytate reduction and its effect on iron status in Malawian children. Ann Trop Paediatr  2002;22:133–6. 10.1179/027249302125000850 [DOI] [PubMed] [Google Scholar]
  • 141. Matkovic  V, Ilich  JZ, Andon  MB, Hsieh  LC, Tzagournis  MA, Lagger  BJ, et al.  Urinary calcium, sodium, and bone mass of young females. Am J Clin Nutr  1995;62:417–25. 10.1093/ajcn/62.2.417 [DOI] [PubMed] [Google Scholar]
  • 142. Tesar  R, Notelovitz  M, Shim  E, Kauwell  G, Brown  J. Axial and peripheral bone density and nutrient intakes of postmenopausal vegetarian and omnivorous women. Am J Clin Nutr  1992;56:699–704. 10.1093/ajcn/56.4.699 [DOI] [PubMed] [Google Scholar]
  • 143. Itoh  R, Suyama  Y. Sodium excretion in relation to calcium and hydroxyproline excretion in a healthy Japanese population. Am J Clin Nutr  1996;63:735–40. 10.1093/ajcn/63.5.735 [DOI] [PubMed] [Google Scholar]
  • 144. Weaver  CM, Proulx  WR, Heaney  R. Choices for achieving adequate dietary calcium with a vegetarian diet. Am J Clin Nutr  1999;70:543S–8S. 10.1093/ajcn/70.3.543s [DOI] [PubMed] [Google Scholar]
  • 145. Holick  MF. Sunlight, UV radiation, vitamin D, and skin cancer: how much sunlight do we need?  Adv Exp Med Biol  2020;1268:19–36. 10.1007/978-3-030-46227-7_2 [DOI] [PubMed] [Google Scholar]
  • 146. Hahn  J, Cook  NR, Alexander  EK, Friedman  S, Walter  J, Bubes  V, et al.  Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ  2022;376:e066452. 10.1136/bmj-2021-066452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147. Chandler  PD, Chen  WY, Ajala  ON, Hazra  A, Cook  N, Bubes  V, et al.  Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open  2020;3:e2025850. 10.1001/jamanetworkopen.2020.25850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148. Chen  H, Shen  J, Xuan  J, Zhu  A, Ji  JS, Liu  X, et al.  Plant-based dietary patterns in relation to mortality among older adults in China. Nat Aging  2022;2:224–30. 10.1038/s43587-022-00180-5 [DOI] [PubMed] [Google Scholar]
  • 149. Kim  J, Kim  H, Giovannucci  EL. Plant-based diet quality and the risk of total and disease-specific mortality: a population-based prospective study. Clin Nutr  2021;40:5718–25. 10.1016/j.clnu.2021.10.013 [DOI] [PubMed] [Google Scholar]
  • 150. Thompson  AS, Tresserra-Rimbau  A, Karavasiloglou  N, Jennings  A, Cantwell  M, Hill  C, et al.  Association of healthful plant-based diet adherence with risk of mortality and major chronic diseases among adults in the UK. JAMA Netw Open  2023;6:e234714. 10.1001/jamanetworkopen.2023.4714 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151. Mirtschink  P, Jang  C, Arany  Z, Krek  W. Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease. Eur Heart J  2017;39:2497–505. 10.1093/eurheartj/ehx518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152. Taylor  SR, Ramsamooj  S, Liang  RJ, Katti  A, Pozovskiy  R, Vasan  N, et al.  Dietary fructose improves intestinal cell survival and nutrient absorption. Nature  2021;597:263–7. 10.1038/s41586-021-03827-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153. O’Donnell  M, Mente  A, Alderman  MH, Brady  AJB, Diaz  R, Gupta  R, et al.  Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. Eur Heart J  2020;41:3363–73. 10.1093/eurheartj/ehaa586 [DOI] [PubMed] [Google Scholar]
  • 154. Wenstedt  EF, Verberk  SG, Kroon  J, Neele  AE, Baardman  J, Claessen  N, et al.  Salt increases monocyte CCR2 expression and inflammatory responses in humans. JCI Insight  2019;4:e130508. 10.1172/jci.insight.130508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155. Mozaffarian  D, Katan  MB, Ascherio  A, Stampfer  MJ, Willett  WC. Trans fatty acids and cardiovascular disease. N Engl J Med  2006;354:1601–13. 10.1056/NEJMra054035 [DOI] [PubMed] [Google Scholar]
  • 156. Gebauer  SK, Destaillats  F, Dionisi  F, Krauss  RM, Baer  DJ. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am J Clin Nutr  2015;102:1339–46. 10.3945/ajcn.115.116129 [DOI] [PubMed] [Google Scholar]
  • 157. Piercy  KL, Troiano  RP, Ballard  RM, Carlson  SA, Fulton  JE, Galuska  DA, et al.  The physical activity guidelines for Americans. Jama  2018;320:2020–8. 10.1001/jama.2018.14854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158. Hu  Y, Hu  FB, Manson  JE. Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc  2019;8:e013543. 10.1161/JAHA.119.013543 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Most extracted data and study materials are available from previously published research. Additional data extracted from the corresponding author of included studies will be shared upon reasonable request.


Articles from European Heart Journal are provided here courtesy of Oxford University Press

RESOURCES